Equity Overview
Price & Market Data
Price: $0.628
Daily Change: +$0.0078 / 1.24%
Range: $0.62 - $0.659
Market Cap: $56,423,944
Volume: 117,521
Performance Metrics
1 Week: 15.59%
1 Month: -22.24%
3 Months: -2.45%
6 Months: -57.49%
1 Year: -66.96%
YTD: -39.28%
Company Details
Employees: 12
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.